Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Holstein

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Expert Opinion on Therapeutic Patents|April 27, 2019
A patent review of bisphosphonates in treating bone diseaseSarah A Holstein
Hematology. American Society of Hematology. Education Program|December 9, 2022
Beyond the cell: novel noncellular immunotherapy approaches to multiple myelomaSarah A Holstein
JCO Oncology Practice|February 12, 2020
Autologous Stem-Cell Transplantation for Myeloma: Here to Stay?Sarah A Holstein
Clinical Pharmacology and Therapeutics|May 19, 2025
A Reflection on the Evolution of Antibody-Based Therapies in Oncology: Trastuzumab as an Exemplar-Commentary on Dijkers et alSarah A Holstein
Clinical Pharmacology and Therapeutics|January 17, 2025
Leveraging Real-World Data to Address Potential Methadone Drug-Drug InteractionsSarah A Holstein
Oncology (Williston Park, N.Y.)|July 18, 2022
Current Frontline Treatment of Multiple MyelomaSarah A Holstein
Clinical Pharmacology and Therapeutics|November 10, 2025
Home Is Where the Research Is: The Promise of Decentralized Clinical TrialsSarah A Holstein
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Ciltacabtagene autoleucel for the treatment of multiple myelomaSarah A Holstein
Journal of Oncology Practice|July 12, 2018
Present and Future of Immunotherapy in the Management of Multiple MyelomaMuhamed Baljevic, Sarah A Holstein
Expert Review of Clinical Pharmacology|January 21, 2022
The era of lenalidomide maintenance therapy in multiple myeloma: settings for achieving best outcomesMeghana Kesireddy, Sarah A Holstein
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Expert Opinion on Therapeutic Patents|April 27, 2019
A patent review of bisphosphonates in treating bone diseaseSarah A Holstein
Hematology. American Society of Hematology. Education Program|December 9, 2022
Beyond the cell: novel noncellular immunotherapy approaches to multiple myelomaSarah A Holstein
JCO Oncology Practice|February 12, 2020
Autologous Stem-Cell Transplantation for Myeloma: Here to Stay?Sarah A Holstein
Clinical Pharmacology and Therapeutics|May 19, 2025
A Reflection on the Evolution of Antibody-Based Therapies in Oncology: Trastuzumab as an Exemplar-Commentary on Dijkers et alSarah A Holstein
Clinical Pharmacology and Therapeutics|January 17, 2025
Leveraging Real-World Data to Address Potential Methadone Drug-Drug InteractionsSarah A Holstein
Oncology (Williston Park, N.Y.)|July 18, 2022
Current Frontline Treatment of Multiple MyelomaSarah A Holstein
Clinical Pharmacology and Therapeutics|November 10, 2025
Home Is Where the Research Is: The Promise of Decentralized Clinical TrialsSarah A Holstein
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Ciltacabtagene autoleucel for the treatment of multiple myelomaSarah A Holstein
Journal of Oncology Practice|July 12, 2018
Present and Future of Immunotherapy in the Management of Multiple MyelomaMuhamed Baljevic, Sarah A Holstein
Expert Review of Clinical Pharmacology|January 21, 2022
The era of lenalidomide maintenance therapy in multiple myeloma: settings for achieving best outcomesMeghana Kesireddy, Sarah A Holstein
Pageof 14